Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WSK-IM02
- Development stage
- Phase 1
- Lead developer
- WestVac Biopharma
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intratumoral
01
Overview
WSK-IM02 is an experimental in situ cancer vaccine being developed by WestVac Biopharma for the treatment of various solid tumors. The drug consists of an oxidized nucleic acid formulated within a lipid complex (liposomes) designed to act as an immunostimulant. Its mechanism of action involves in situ vaccination, where the drug is injected directly into a tumor site to activate the local immune environment. This localized stimulation is intended to trigger a broader systemic antitumor immune response, potentially addressing both the primary tumor and metastatic lesions. The development of WSK-IM02 is led by a team associated with West China Hospital of Sichuan University, and it is currently in early-stage clinical trials to assess its safety and efficacy.
- Other names
- pMVA-1 lipid complex for injectionpMVA1 lipid complex for injectionpMVA 1 lipid complex for injection
Beyond the preview
Go deeper on WSK-IM02.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WSK-IM02.